Additionally, a negative regulator of glycolysis associated with thyroid cancer growth utilizes the RAF/MEK/ERK pathway to increase glycolysis via GLUT1 overexpression while simultaneously suppressing mitochondrial respiration in thyroid cells [32]. Here, MAP2K7 is linked to thyroid cancer.